What the USPTO’s latest memorandum means for life sciences Section 101 eligibility
The USPTO’s 4 December 2025 memorandum on subject-matter eligibility declarations (SMEDs) seeks to raise awareness of the “underutilized path” of…
Subscribe here for related insights, breaking industry news and cutting-edge market analysis from global experts.
IAM is universally acknowledged as the world’s leading intelligence platform for practising lawyers working in intellectual property and patent law.
IAM is your trusted partner in IP value creation. Our suite of tools, intelligence, legal know-how and data empowers you to mitigate risks, optimise operations, spot new commercial opportunities and maximise the value of your patent, trade secret and other IP assets. Stay ahead of the curve and anticipate developments affecting IP businesses around the globe with our expert market analysis and intelligence.
Popular articles from this firm
